Summary
This case study documents the challenges faced by a mid-sized biopharma conducting an adhesive capsulitis trial, particularly regarding stalled enrollment due to the COVID-19 pandemic. The recruitment efforts were hindered by inadequate media outreach and a lack of tracking for referrals, which prevented effective action by sites and sponsors. WCG Clinical provided recruitment and retention solutions that enhanced visibility into referral channels and participant journeys. As a result, enrollment was completed nearly three months ahead of the projected timeline. The study highlights the deployment of a multi-channel media outreach strategy and the utilization of the My Patient platform for real-time tracking of referrals. This approach allowed for better follow-up support and improved the overall experience for potential participants. The case study emphasizes the importance of focusing on qualified enrollments rather than mere impressions, showcasing the effectiveness of WCG's agile support in addressing specific site needs.
